Donatella Ieluzzi

Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C

Davide Bitetto, Giovanna Fattovich, Carlo Fabris et al. · Hepatology · 2011 · 133 citations

Pharmacy, Immunology, Infectious Diseases +15

Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network

Loreta A. Kondili, Giovanni Battista Gaeta, Maurizia Rossana Brunetto et al. · PLoS ONE · 2017 · 114 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +11

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C

Edmondo Falleti, Davide Bitetto, Carlo Fabris et al. · Hepatology · 2012 · 68 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

Loreta A. Kondili, Giovanni Battista Gaeta, Donatella Ieluzzi et al. · PLoS ONE · 2017 · 46 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Forecasting Hepatitis C liver disease burden on real‐life data. Does the <i>hidden iceberg</i> matter to reach the elimination goals?

Loreta A. Kondili, Sarah Robbins Scott, Sarah Blach et al. · Liver International · 2018 · 43 citations · Full text

Public Health, Health Sciences, Infectious Disease Control +16